NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Atlassian [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Atlassian [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Avaya Holdings Corp. (NYSE: AVYA) (OTC: AVYAW) between [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of PLDT Inc. (NYSE: PHI) between [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depository Shares ("ADSs") of Argo Blockchain plc (NASDAQ: ARBK): [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. (NYSE: GWH) between August 11, 2022 and [...] Read more »
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and [...] Read more »
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), ("Entera" or the "Company") a late–clinical stage, leader in the development of orally delivered peptides and [...] Read more »
London, U.K., Feb. 13, 2023 (GLOBE NEWSWIRE) — OPEN Health, a pre–eminent global provider of scientific communications and HEOR & market access services, announced the acquisition of Acsel Health ("Acsel"), a New [...] Read more »